5.96
price down icon0.83%   -0.05
after-market アフターアワーズ: 5.85 -0.11 -1.85%
loading
前日終値:
$6.01
開ける:
$5.98
24時間の取引高:
144.99K
Relative Volume:
1.42
時価総額:
$151.72M
収益:
-
当期純損益:
$-22.38M
株価収益率:
-4.227
EPS:
-1.41
ネットキャッシュフロー:
$-15.54M
1週間 パフォーマンス:
-0.75%
1か月 パフォーマンス:
-5.10%
6か月 パフォーマンス:
-30.09%
1年 パフォーマンス:
-3.72%
1日の値動き範囲:
Value
$5.85
$6.1371
1週間の範囲:
Value
$5.85
$6.30
52週間の値動き範囲:
Value
$4.44
$11.80

Nuvectis Pharma Inc Stock (NVCT) Company Profile

Name
名前
Nuvectis Pharma Inc
Name
セクター
Healthcare (1141)
Name
電話
360-837-7232
Name
住所
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Name
職員
13
Name
Twitter
Name
次回の収益日
2024-08-07
Name
最新のSEC提出書
Name
NVCT's Discussions on Twitter

NVCT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NVCT
Nuvectis Pharma Inc
5.96 153.00M 0 -22.38M -15.54M -1.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.79 106.37B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.46 59.90B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.63 60.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
796.92 49.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.10 36.88B 4.56B -176.77M 225.30M -1.7177

Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-02 開始されました Maxim Group Buy
2025-03-17 開始されました Laidlaw Buy
2022-07-13 開始されました Ladenburg Thalmann Buy

Nuvectis Pharma Inc (NVCT) 最新ニュース

pulisher
10:40 AM

Technical analysis overview for Nuvectis Pharma Inc. stockJuly 2025 Fed Impact & Consistent Profit Trading Strategies - newser.com

10:40 AM
pulisher
09:06 AM

Nuvectis Pharma (NASDAQ:NVCT) Given Sell (E+) Rating at Weiss Ratings - MarketBeat

09:06 AM
pulisher
03:15 AM

Using flow based indicators on Nuvectis Pharma Inc.Oil Prices & Long-Term Growth Stock Strategies - newser.com

03:15 AM
pulisher
Oct 06, 2025

Applying Wyckoff theory to Nuvectis Pharma Inc. stockNew Guidance & Smart Allocation Stock Reports - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 01:41:39 - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Price momentum metrics for Nuvectis Pharma Inc. explained2025 Key Lessons & Weekly Top Stock Performers List - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Using economic indicators to assess Nuvectis Pharma Inc. potential2025 Performance Recap & AI Powered Buy and Sell Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to use Fibonacci retracement on Nuvectis Pharma Inc.Market Growth Review & Low Drawdown Investment Ideas - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Momentum divergence signals in Nuvectis Pharma Inc. chartJuly 2025 Recap & Expert Approved Momentum Trade Ideas - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Using portfolio simulators with Nuvectis Pharma Inc. includedEarnings Growth Summary & Long-Term Safe Return Strategies - newser.com

Oct 02, 2025
pulisher
Sep 28, 2025

Nuvectis Pharma Inc Stock Analysis and ForecastMarket Rumors and News & Market Trend Real-Time Reports - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Goldman Sachs Group Inc. Takes $446,000 Position in Nuvectis Pharma, Inc. $NVCT - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

What drives Nuvectis Pharma Inc stock priceTrading Volume Trends & Small Budget Trading Ideas - Early Times

Sep 27, 2025
pulisher
Sep 27, 2025

Nuvectis Pharma (NASDAQ:NVCT) Shares Up 2.2%Time to Buy? - MarketBeat

Sep 27, 2025
pulisher
Sep 27, 2025

Nuvectis Pharma (NASDAQ:NVCT) Shares Up 2.2% – Time to Buy? - Defense World

Sep 27, 2025
pulisher
Sep 26, 2025

Nuvectis Pharma Appoints Juan Sanchez to Board - The Globe and Mail

Sep 26, 2025
pulisher
Sep 26, 2025

Nuvectis Pharma adds former Intra-Cellular exec to board of directors - Investing.com Nigeria

Sep 26, 2025
pulisher
Sep 25, 2025

Nuvectis Pharma adds former Intra-Cellular exec to board of directors By Investing.com - Investing.com South Africa

Sep 25, 2025
pulisher
Sep 25, 2025

Nuvectis Pharma Appoints Juan Sanchez, MD, To Board - citybiz

Sep 25, 2025
pulisher
Sep 25, 2025

Nuvectis Pharma Appoints Biotech Executive Juan Sanchez, MD, to the Board of Directors - GlobeNewswire

Sep 25, 2025
pulisher
Sep 25, 2025

From $14.6B J&J Deal Success: Nuvectis Pharma Adds Key Biotech Executive to Board Ahead of Phase 1b Trial - Stock Titan

Sep 25, 2025
pulisher
Sep 23, 2025

Is Nuvectis Pharma Inc. forming a reversal pattern2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com

Sep 23, 2025

Nuvectis Pharma Inc (NVCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Nuvectis Pharma Inc (NVCT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Mosseri Marlio Charles
10% Owner
Jun 18 '25
Buy
8.05
28,043
225,746
2,976,203
Mosseri Marlio Charles
10% Owner
Jun 17 '25
Buy
8.11
5,399
43,786
2,948,160
Mosseri Marlio Charles
10% Owner
May 12 '25
Buy
8.11
21,167
171,664
2,942,761
Mosseri Marlio Charles
10% Owner
May 06 '25
Buy
8.59
12,444
106,955
2,896,565
Mosseri Marlio Charles
10% Owner
May 07 '25
Buy
8.59
12,317
105,770
2,908,882
Mosseri Marlio Charles
10% Owner
May 08 '25
Buy
8.65
2,650
22,922
2,911,532
Mosseri Marlio Charles
10% Owner
Feb 07 '25
Buy
5.00
240,000
1,200,000
2,884,121
BENTSUR RON
Chairman & CEO
Dec 24 '24
Buy
4.65
4,500
20,925
3,270,924
Mosseri Marlio Charles
10% Owner
Dec 13 '24
Buy
4.70
17,000
79,900
2,612,000
Poradosu Enrique
Chief Science & Business Off
Nov 19 '24
Buy
4.99
2,000
9,980
1,506,319
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
大文字化:     |  ボリューム (24 時間):